Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Epilepsy & Behavior : E&B|January 15, 2017
Pharmacology of cannabinoids in the treatment of epilepsyTyler E Gaston, Daniel FriedmanCurrent Neurology and Neuroscience Reports|September 9, 2018
Cannabis for the Treatment of Epilepsy: an UpdateTyler E Gaston, Jerzy P SzaflarskiEpilepsy & Behavior : E&B|September 26, 2021
Cannabidiol (CBD) and cognition in epilepsyTyler E Gaston, Roy C Martin, Jerzy P SzaflarskiEpilepsy & Behavior : E&B|April 20, 2019
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsyTyler E Gaston, Magdalena Szaflarski, Barbara Hansen, et al.Epilepsia|August 8, 2017
Interactions between cannabidiol and commonly used antiepileptic drugsTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.The Neurohospitalist|June 19, 2024
Short Report: Clinical Features and Epilepsy Monitoring in an Adult With 22q11.2 Deletion SyndromeMike W Zhang, Stephanie T Bustros, Tyler E Gaston, et al.Epilepsia Open|August 18, 2023
Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access programTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.Regulatory Toxicology and Pharmacology : RTP|March 22, 2020
"Natural" is not synonymous with "Safe": Toxicity of natural products alone and in combination with pharmaceutical agentsTyler E Gaston, Donna L Mendrick, Mary F Paine, et al.Restorative Neurology and Neuroscience|July 9, 2019
Memory response and neuroimaging correlates of a novel cognitive rehabilitation program for memory problems in epilepsy: A pilot studyTyler E Gaston, Sangeeta Nair, Jane B Allendorfer, et al.Epilepsy & Behavior : E&B|June 21, 2019
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsyRoy C Martin, Tyler E Gaston, Matthew Thompson, et al.Pageof 4